{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:36:37Z","timestamp":1791218197763,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.rmr.2010.10.034","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T11:31:20Z","timestamp":1304854280000},"page":"542-555","source":"Crossref","is-referenced-by-count":19,"title":["Les effets ind\u00e9sirables des antituberculeux\u00a0; prise en charge"],"prefix":"10.1016","volume":"28","author":[{"given":"J.","family":"Perriot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9.","family":"Chambonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Eschalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2010.10.034_bib0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Discases Society of America treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0010","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0015","first-page":"11","article-title":"Incidents et accidents du traitement antituberculeux","volume":"10","author":"Gonzales","year":"1996","journal-title":"Rev Prat Med Gen"},{"key":"10.1016\/j.rmr.2010.10.034_bib0020","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1345\/aph.1D525","article-title":"Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors","volume":"38","author":"Shakya","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rmr.2010.10.034_bib0025","first-page":"906","article-title":"H\u00e9patites m\u00e9dicamenteuses\u00a0: diagnostic et prise en charge","volume":"23","author":"Mallat","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2010.10.034_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.medmal.2006.12.006","article-title":"Les effets ind\u00e9sirables des antituberculeux\u00a0: \u00e9pid\u00e9miologie, m\u00e9canismes et conduite \u00e0 tenir","volume":"37","author":"Aouam","year":"2007","journal-title":"Med Mal Inf"},{"key":"10.1016\/j.rmr.2010.10.034_bib0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/thx.51.2.132","article-title":"Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study","volume":"51","author":"Pande","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2010.10.034_bib0045","first-page":"2681","article-title":"Surveillance et accidents de la chimioth\u00e9rapie antituberculeuse","volume":"29","author":"Duroux","year":"1979","journal-title":"Rev Prat"},{"key":"10.1016\/j.rmr.2010.10.034_bib0050","first-page":"81","article-title":"Determining the relation between N-acethyltransferase - 2 acetylator ph\u00e9notype and antituberculosis drug induced hepatitis by molecular biologic tests","volume":"56","author":"Bozok Cetintas","year":"2008","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.rmr.2010.10.034_bib0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00228-006-0111-5","article-title":"CYP2E1\u00a0genotype and isoniazide-induced hepatotoxicity in patients treated for latent tuberculosis","volume":"62","author":"Vuilleumenier","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0060","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/jhep.2002.32102","article-title":"Polymorphism of the N-acetyltransferase-2\u00a0gene as a susceptibility risk factor for antituberculosis drug-induced hepatities","volume":"35","author":"Huang","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.rmr.2010.10.034_bib0065","first-page":"994","article-title":"Drug-metabolising enzyme polymorphisms and predisposition to antituberculosis drug-induced liver injury: a meta-analysis","volume":"12","author":"Sun","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.rmr.2010.10.034_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0761-8425(06)71480-2","article-title":"Neuropathie toxique induite par l\u2019isoniazide\u00a0: pensez \u00e0 la pr\u00e9vention","volume":"23","author":"Seichen","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2010.10.034_bib0075","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1542\/peds.95.5.700","article-title":"Acute isoniazid neurotoxicity in an urban hospital","volume":"95","author":"Binita","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2010.10.034_bib0080","doi-asserted-by":"crossref","unstructured":"Recommandations de la Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise pour la prise en charge de la tuberculose en France. Rev Mal Respir 2004;21(3):3S4\u2013104.","DOI":"10.1016\/S0761-8425(04)71378-9"},{"key":"10.1016\/j.rmr.2010.10.034_bib0085","first-page":"183","article-title":"Neuropathies optiques toxiques graves induites par l\u2019isoniazide","volume":"18","author":"Boulanouar","year":"1995","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1176\/appi.psy.45.6.537","article-title":"Confusion associated with isoniazed induced pyridoxine deficiency","volume":"45","author":"Reeves","year":"2004","journal-title":"Psychosomatics"},{"key":"10.1016\/j.rmr.2010.10.034_bib0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-199510030-00009","article-title":"Isoniazid, tricyclics and the \u201ccheese reaction\u201d","volume":"10","author":"Di Martini","year":"1995","journal-title":"Int Clin Psycho Pharmacol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/appi.neuropsych.17.2.256","article-title":"Persisting dementia after isoniazid overdose","volume":"17","author":"Mc Lay","year":"2005","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"10.1016\/j.rmr.2010.10.034_bib0105","first-page":"129","article-title":"Traitement antituberculeux et effets secondaires psychiatriques\u00a0: psychiatrie et m\u00e9decine","volume":"8","author":"Bazin","year":"1993","journal-title":"Ann Psychiatr"},{"key":"10.1016\/j.rmr.2010.10.034_bib0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1183\/09031936.04.00053804","article-title":"G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia","volume":"23","author":"Cormican","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2010.10.034_bib0115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF01711541","article-title":"Isoniazid overdose: four case reports and review of the literature","volume":"21","author":"Alvarez","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0120","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0091270003253304","article-title":"Isoniazid-induced anaphylaxis","volume":"43","author":"Crook","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0125","first-page":"660","article-title":"Isoniazid induced pellagra and the N-acetyltransferase gene genotype","volume":"56","author":"Tatsuyuki","year":"1999","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.rmr.2010.10.034_bib0130","first-page":"341","article-title":"Leukopenia due to antituberculous chemotherapy including rifampicin and isoniazid","volume":"79","author":"Nagayama","year":"2004","journal-title":"Kekkaku"},{"key":"10.1016\/j.rmr.2010.10.034_bib0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2004.01.607","article-title":"Drug rash with cosinophilia and systemic symptoms (DRESS) secondary to antituberculosis therapy with features of isoniazid toxicity","volume":"113","author":"Ditto","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pneumo.2009.08.006","article-title":"Lupus eryth\u00e9mateux systh\u00e9mique grave induit par l\u2019isoniazide","volume":"65","author":"Rakoston","year":"2009","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.rmr.2010.10.034_bib0145","first-page":"172","article-title":"Recurrent acute pancreatitis after isoniazid","volume":"62","author":"Chow","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0150","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1378\/chest.91.4.620","article-title":"Severe febrile reaction to isoniazid","volume":"91","author":"Gabrail","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2010.10.034_bib0155","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1590\/S1806-37132008001100014","article-title":"Gynecomastia: a rare adverse effect of isoniazid","volume":"34","author":"Morrone","year":"2008","journal-title":"J Bras pneumol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0160","first-page":"51","article-title":"Isoniazid induced gynecomastia: a case report","volume":"56","author":"Carg","year":"2009","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.rmr.2010.10.034_bib0165","first-page":"1212","article-title":"Toxicit\u00e9 h\u00e9patique des antituberculeux\u00a0: r\u00f4le des diff\u00e9rents m\u00e9dicaments\u00a0: 199\u00a0observations","volume":"22","author":"Altam","year":"1993","journal-title":"Presse Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0170","doi-asserted-by":"crossref","unstructured":"Godel A, Marchou B. Rifampicine. EMC (Elsevier Masson Sas, Paris), Trait\u00e9 de M\u00e9decine Akos, 5-0080; 2007.","DOI":"10.1016\/S1634-6939(07)45856-2"},{"key":"10.1016\/j.rmr.2010.10.034_bib0175","first-page":"376","article-title":"A case of rifampicin associated pseudomembranous colitis","volume":"43","author":"Kim","year":"2004","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAJ.0b013e31819f1eec","article-title":"Rifampin-associated pseudomenbranous colitis","volume":"338","author":"Chen","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rmr.2010.10.034_bib0185","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(94)90782-X","article-title":"Eosinophilie colitis due to rifampicin","volume":"344","author":"Lange","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2010.10.034_bib0190","first-page":"1167","article-title":"Manifestations d\u2019hypersensibilit\u00e9 \u00e0 la rifampicine","volume":"32","author":"Fenniche","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005792-199911000-00001","article-title":"Hypersensitivity reactions to rifampicin. Pathogenic mechanisms, clinical manifestations, management strategies and review of the anaphylactic-like reactions","volume":"78","author":"Martinez","year":"1999","journal-title":"Medicine"},{"key":"10.1016\/j.rmr.2010.10.034_bib0200","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/thorax.57.11.1000","article-title":"Pneumonitis induced by rifampicin","volume":"7","author":"Kunichika","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2010.10.034_bib0205","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ndt\/13.4.924","article-title":"Rifampicin induced acute renal failure: a series of 60\u00a0patients","volume":"13","author":"Covic","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rmr.2010.10.034_bib0210","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/ajkd.2002.35675","article-title":"Acute renal failure due to rifampicin: a study of 25\u00a0patients","volume":"40","author":"Thangamani","year":"2002","journal-title":"Am J Kidneys Dis"},{"key":"10.1016\/j.rmr.2010.10.034_bib0215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ndt\/16.1.190-a","article-title":"Continuous rifampicin administration inducing acute renal failure","volume":"16","author":"Bassilios","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rmr.2010.10.034_bib0220","first-page":"2037","article-title":"Accident immunoallergique grave chez un patient trait\u00e9 quotidiennement depuis deux mois par rifampicine","volume":"28","author":"Fardet","year":"1999","journal-title":"Presse Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0225","doi-asserted-by":"crossref","unstructured":"Dautzenberg B, Frechet-Jachym M, Maffre JP et al. Quand ne pas appliquer le traitement standard de la tuberculose maladie\u00a0? Rev Mal Respir 2004;21(suppl 3):3S75\u201397.","DOI":"10.1016\/S0761-8425(04)71390-X"},{"key":"10.1016\/j.rmr.2010.10.034_bib0230","unstructured":"Pr\u00e9vention et prise en charge de la tuberculose en France. Recommandations du groupe de travail du Conseil Sup\u00e9rieur d\u2019hygi\u00e8ne publique de France (2002\u20132003). Rev Mal Respir 2003;20(6):7S3\u2013105."},{"key":"10.1016\/j.rmr.2010.10.034_bib0235","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003088-200443110-00003","article-title":"Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS","volume":"43","author":"Panomvana","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rmr.2010.10.034_bib0240","unstructured":"Jouveshommes S, Dautzenberg B. La chimioth\u00e9rapie antituberculeuse. Rev Mal Respir 1997;14(suppl 5):5S88\u2013104."},{"key":"10.1016\/j.rmr.2010.10.034_bib0245","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1378\/chest.123.3.967","article-title":"Fatal liver injury associated with rifampicin-pyrazinamide treatment of latent tuberculosis infection","volume":"23","author":"Castro","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2010.10.034_bib0250","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004836-199706000-00019","article-title":"Pyrazinamide-induced granulomatous hepatitis","volume":"24","author":"Knobel","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0255","first-page":"115","article-title":"Hyperuricemia and arthralgia during pyrazinamide treatment","volume":"37","author":"Inoue","year":"1999","journal-title":"Nihon Kokyyuki Zasski"},{"key":"10.1016\/j.rmr.2010.10.034_bib0260","first-page":"136","article-title":"Pyrazinamide-induced hyperuricemia in patients taking antituberculous therapy","volume":"14","author":"Solangi","year":"2004","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.rmr.2010.10.034_bib0265","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.reval.2009.04.005","article-title":"R\u00e9action allergique aux antituberculeux majeurs","volume":"49","author":"Lafourcade","year":"2009","journal-title":"Rev Fr Allergol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0270","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1034\/j.1398-9995.2002.23832_9.x","article-title":"Adverse reactions to pyrazinamide","volume":"57","author":"Ribi","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2010.10.034_bib0275","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0761-8425(08)74987-8","article-title":"Un effet secondaire grave du traitement antituberculeux\u00a0: la thrombop\u00e9nie induite au pyrazinamide","volume":"25","author":"Roseau","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2010.10.034_bib0280","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4065\/79.5.701","article-title":"Ocular ethambutol toxicity","volume":"79","author":"Herchline","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rmr.2010.10.034_bib0285","unstructured":"Maalouf T, Trechot P, Raspiller A. Latrogenici\u00e9 oculaire des traitements syst\u00e9miques. EMC (Elsevier, Paris), Trait\u00e9 de M\u00e9decine. AKOS, 6-0350; 1998."},{"key":"10.1016\/j.rmr.2010.10.034_bib0290","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bjo.2008.148502","article-title":"Prospective evaluation of visual function for early detection of ethambutol toxicity","volume":"93","author":"Menon","year":"2009","journal-title":"Br J Ophtalmol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0295","first-page":"190","article-title":"Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway","volume":"40","author":"Heng","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.rmr.2010.10.034_bib0520","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.survophthal.2009.10.005","article-title":"Drug-induced Optic Neuropathy, TB or Not TB","volume":"55","author":"Pradhan","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0305","first-page":"967","article-title":"Ethambutol-induced optical neuropathy: risk of overdosing in obese subjects","volume":"12","author":"Hasenbosch","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.rmr.2010.10.034_bib0310","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/bjo.2004.058099","article-title":"Multifocal electroretinogram demonstrated maculae toxicity associated with ethambutol related optic neuropathy","volume":"89","author":"Lai","year":"2005","journal-title":"Br Ophthalmol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0315","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/08820530701457134","article-title":"Ethambutol neuroretinopathy","volume":"22","author":"Vistamehr","year":"2007","journal-title":"Semin Ophtalmol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0320","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1183\/09031936.95.08050866","article-title":"Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement","volume":"8","author":"Wong","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2010.10.034_bib0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-199936020-00001","article-title":"Once daily aminoglycoside therapy: is it less toxic than multiple daily doses and how should it be monitored","volume":"36","author":"Barclay","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rmr.2010.10.034_bib0330","doi-asserted-by":"crossref","unstructured":"Boussekey N, Alfandaris S. Aminosides. EMC (Elsevier SAS, Paris), Trait\u00e9 de M\u00e9decine AKOS, 5-0030; 2006.","DOI":"10.1016\/S1634-6939(06)45852-X"},{"key":"10.1016\/j.rmr.2010.10.034_bib0335","first-page":"279","article-title":"Tuberculose et grossesse","volume":"5","author":"Dautzenberg","year":"1988","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2010.10.034_bib0340","first-page":"143","article-title":"Two years review of cutareous adverse drug reaction from first-line antituberculeux drugs","volume":"62","author":"Tan","year":"2007","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.rmr.2010.10.034_bib0345","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1345\/aph.1E430","article-title":"A rare case of streptomycin-induced toxic epidermal necrolysis with tuberculosis: a therapeutic dilemma","volume":"39","author":"Hmounda","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rmr.2010.10.034_bib0350","unstructured":"Dautzenberg B, Dekimeche. Chimioth\u00e9rapie antituberculeuse. Encycl Med Chir (Paris, France). Pneumologie, 6-019-A-35; 1995. 10\u00a0p."},{"key":"10.1016\/j.rmr.2010.10.034_bib0355","series-title":"Clinical tuberculosis","author":"Davies","year":"1994"},{"key":"10.1016\/j.rmr.2010.10.034_bib0360","first-page":"719","article-title":"Modalit\u00e9s th\u00e9rapeutiques de la tuberculose pulmonaire","volume":"40","author":"Leophonte","year":"1990","journal-title":"Rev Prat"},{"key":"10.1016\/j.rmr.2010.10.034_bib0365","first-page":"332","article-title":"Les nouveaux antituberculeux","volume":"18","author":"Marigot-Onttandy","year":"2009","journal-title":"Reanim"},{"key":"10.1016\/j.rmr.2010.10.034_bib0370","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.00749-08","article-title":"New drugs against turberculosis: problems, progress, and evaluation agents in clinical development","volume":"53","author":"Van der Boogaard","year":"2009","journal-title":"Antimicrob Chemotherap"},{"key":"10.1016\/j.rmr.2010.10.034_bib0375","first-page":"71","article-title":"Moxifloxacine induced torsades de pointes","volume":"15","author":"Sherazi","year":"2008","journal-title":"Cardiol J"},{"key":"10.1016\/j.rmr.2010.10.034_bib0380","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1086\/428055","article-title":"Antimicrobial safety: focus fluoroquinolones","volume":"41","author":"Owens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2010.10.034_bib0385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MAJ.0b013e31812f65fc","article-title":"Gatifloxacin produces both hypoglycemia and hyperglycemia: a retrospective study","volume":"335","author":"Hoerian","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rmr.2010.10.034_bib0390","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2165\/00003495-200767140-00007","article-title":"Fluoroquinolones for the treatment of pulmonary tuberculosis","volume":"67","author":"Moadebi","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.rmr.2010.10.034_bib0395","first-page":"606","article-title":"Linezolid for the treatment of patients with mycobacterial infections review","volume":"11","author":"Ntziora","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.rmr.2010.10.034_bib0400","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multi-resistant tuberculosis","volume":"56","author":"Fortun","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rmr.2010.10.034_bib0405","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/dkq017","article-title":"Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis New-York city; 2000\u201306","volume":"65","author":"Anger","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rmr.2010.10.034_bib0410","first-page":"CD005159","article-title":"Rifabutin for treating pulmonary tuberculosis","volume":"4","author":"Davies","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2010.10.034_bib0415","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/14656560802694564","article-title":"Tuberculosis pharmacotherapy: trategies to optimize patient care","volume":"10","author":"Mitnick","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.rmr.2010.10.034_bib0420","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/clinids\/21.3.594","article-title":"Adverse events associated with high dose rifafutin in macrolid-containging regiments for mycobacterium arium intracellulare lung disease","volume":"21","author":"Griffith","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2010.10.034_bib0425","first-page":"185","article-title":"Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or monnucleoside reverse transcriptase inhibitors","volume":"49","author":"Center for Disease Control Prevention (CDC)","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.rmr.2010.10.034_bib0430","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0761-8425(08)56025-6","article-title":"Particularit\u00e9s du traitement de la tuberculose chez l\u2019enfant","volume":"25","author":"Marquet","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2010.10.034_bib0435","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0761-8425(08)56029-3","article-title":"Pr\u00e9vention des complications du traitement antituberculeux","volume":"25","author":"Terrioux","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2010.10.034_bib0440","first-page":"1203","article-title":"Tolerability of antituberculosis treatment and HIV serostatus","volume":"11","author":"Lanternier","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.rmr.2010.10.034_bib0445","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.rmr.2010.01.010","article-title":"Syndrome de Lyell chez trois malades VIH (+) sous traitement antituberculeux","volume":"27","author":"Kouassi","year":"2010","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2010.10.034_bib0450","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/thx.2006.058867","article-title":"Adverse events and treatments interruption in tuberculosis patients with and without HIV coinfection","volume":"61","author":"Breen","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2010.10.034_bib0455","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0755-4982(06)74893-X","article-title":"R\u00e9actions paradoxales","volume":"35","author":"Martinez","year":"2006","journal-title":"Presse Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0460","first-page":"92","article-title":"Hepatites B or Hepatites C co-infection in individuals infected human immuno deficiency virus and effect of antituberculosis drugs on liver function","volume":"52","author":"Padmapriyadarsini","year":"2006","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.rmr.2010.10.034_bib0465","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2010.10.034_bib0470","first-page":"1","article-title":"Adverse effects other than liver dysfunctiunction in treatment of latent tuberculosis infection by isoniazid","volume":"82","author":"Ito","year":"2007","journal-title":"Kekkaku"},{"key":"10.1016\/j.rmr.2010.10.034_bib0475","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis non-HIV infected persons","volume":"2","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2010.10.034_bib0480","unstructured":"Severe isoniazid-associated liver injuries among persons being treat portalent tuberculosis infection, United States, 2004\u20132008. CDC. MMWR Morb Mortal Wkly Rep 2010;59(8):224\u20139."},{"key":"10.1016\/j.rmr.2010.10.034_bib0485","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1590\/S1806-37132008001200010","article-title":"Adverse effects of tuberculosis treatment: experience at an outpatient clinic of teaching hospital in the city of Sao Paulo, Brazil","volume":"34","author":"Vieira","year":"2008","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0490","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7525-8-6","article-title":"Measuring health-related quality of life in tuberculosis: a systematic review","volume":"8","author":"Guo","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.rmr.2010.10.034_bib0495","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/lt.20839","article-title":"Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and non standard antituberculous therapy","volume":"12","author":"Idilman","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.rmr.2010.10.034_bib0500","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.reval.2009.10.004","article-title":"R\u00e9actions aux antituberculeux\u00a0: prise en charge allergologique \u00e0 propos de quatre cas","volume":"50","author":"Birnbaum","year":"2010","journal-title":"Rev Fr Allergol"},{"key":"10.1016\/j.rmr.2010.10.034_bib0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199512010-00001","article-title":"Ovoidance and management of adverse reactions to antituberculosis drugs","volume":"12","author":"Patel","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.rmr.2010.10.034_bib0510","first-page":"88","article-title":"Accoutumance orale rapide \u00e0 la rifampicine en suspension","volume":"45","author":"Ben M\u2019Rad","year":"2005","journal-title":"Rev Fr Allergol Immunol Clin"},{"key":"10.1016\/j.rmr.2010.10.034_bib0515","first-page":"275","article-title":"Adverse events related to multi drug-resistant tuberculosis treatment, Latvia, 2000\u20132004","volume":"14","author":"Bloss","year":"2010","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S076184251100088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S076184251100088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T17:24:30Z","timestamp":1686072270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S076184251100088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S076184251100088X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2010.10.034","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}